Citadel Advisors »

Biorestorative Therapies shares owned by Citadel Advisors

Quarter-by-quarter ownership of Biorestorative Therapies (BRTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Biorestorative Therapies

Tip: Access up to 7 years of quarterly data

All positions including Biorestorative Therapies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biorestorative Therapies by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $152k 106k 1.43
2024-12-31 $31k 22k 1.43

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Biorestorative Therapies

Citadel Advisors
Vanguard Group
Geode Capital Management
Wealth Alliance
Intl Fcstone
Morgan Stanley
Virtu Financial
State Street Corporation
Tower Research Capital
Advisor Group Holdings
Wells Fargo & Company
SBI Securities
TD Waterhouse Canada

View all funds holding Biorestorative Therapies